[HTML][HTML] Design and rationale for REVERXaL: A real-world study of patients with factor Xa inhibitor–associated major bleeds

R Alikhan, M Nour, M Yasaka, R Ofori-Asenso… - Thrombosis …, 2024 - Elsevier
Background The prevalence of anticoagulation treatment is increasing as an aging global
population faces a high burden of cardiovascular comorbidities. Direct oral anticoagulants …